To evaluate the potential therapeutic effects of TSPO PAM in vivo, several inflammatory and neuropathic pain models were selected for which Ro5-4864 has been discovered to have therapeutic effects: the formalin-induced inflammatory pain model, CIA model and CCI model of neuropathic pain. The gene discussed is TSPO; the disease is neuropathic pain.